Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

952

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2029

Conditions
Esophageal CancerGastric Cancer
Interventions
OTHER

Surveillance protocol

Imaging surveillance will entail a computed tomography scan of the chest, abdomen and pelvis, as well as clinical review, every 6 months for 36 months post surgery along with an endoscopy at 12 months post surgery.

Trial Locations (13)

Unknown

University Hospital Cologne, Cologne

Mercy University Hospital, Cork

Trinity St. James's Cancer Institute, Dublin

Galway University Hospital, Galway

Fondazione Policlinico Universitario Agostino Gemelli, Roma

Oslo University Hospital, Oslo

University Hospital of Northern Norway, Tromsø

St. Olav University Hospital, Trondheim

Linköping University Hospital, Linköping

Skåne University Hospital, Lund

Örebro University Hospital, Örebro

Karolinska Institutet, Stockholm

Uppsala University Hospital, Uppsala

All Listed Sponsors
collaborator

Trinity St. James's Cancer Institute

UNKNOWN

collaborator

University of Oxford

OTHER

collaborator

Karolinska Institutet

OTHER

lead

University of Dublin, Trinity College

OTHER